1. Adrenaline was infused intravenously in nine normal volunteers to plasma concentrations similar to those found after myocardial infarction. This study was undertaken on three occasions after 5 days' treatment with placebo or the gadrenoceptor antagonists, atenolol or timolol.
Introduction
There is increasing evidence of the link between &adrenoceptors and a membrane-bound Na+/K+-ATPase in skeletal muscle. In animals this has been demonstrated principally in studies of rat soleus muscle [l] . In man, Preceptor agonists increase the intracellular concentration of potassium in erythrocytes and decrease intracellular sodium [2] .
The subtype of adrenoceptor involved in this potassium influx has been shown to be flZ from studies of both human volunteers and patients undergoing open heart surgery [3-51. This mechanism may have important implications for patients with acute myocardial infarction. These patients have increased circulating catecholamine levels [6, 71 , especially of adrenaline, which may act both directly on pacemaker cells and indirectly by the above mechanism to provoke arrhythmias. In the indirect mechanism, increased adrenaline may stimulate potassium influx into cells causing systemic hypokalaemia. Hypokalaemia after myocardial infarction is associated with an increased incidence of ventricular arrhythmias [ 8-101. Adrenaline has already been shown in much higher doses to lower the serum potassium in man [ 111. We have investigated whether the circulating adrenaline levels observed after myocardial infarction can stimulate potassium influx and cause significant hypokalaemia in normal volunteers. We have also investigated the effect of cardioselective and non-selective 0-blockers on these potassium changes.
A preliminary report of this study was presented at the Medical Research Society in London in December 1981 [12] .
Methods
Nine normal male volunteers aged 24-32 years were studied. They had normal electrocardiograms, chest radiographs, serum biochemistry and haematology. They were infused with adrenaline to produce plasma adrenaline levels similar to those found after myocardial infarction [6] . Informed written consent was obtained from each subject. In addition, the study was approved by the Research and Ethical Committee of the Northern District of the Greater Glasgow Health Board. Each subject was studied on three occasions on the fifth day of treatment with either timolol 10mg twice daily (Blocadren: Merck, Sharp and Dohme Ltd), atenolol 50mg twice daily (Tenormin: Stuart Pharmaceuticals Ltd) or placebo in a randomized single blind fashion.
Exercise-induced tachycardia was measured on days 2 and 4 preceding each study. The doses of atenolol and timolol were then adjusted in each individual to produce the same degree of PIblockade (i.e. 20% reduction in exercise-induced tachycardia) with each treatment. On each study day, intravenous cannulae were inserted into the antecubital veins of both arms. They then received three 90min infusions of 5% glucose solution containing ascorbic acid (1 mg/ml) and 0,O.Ol and 0.06 pg min-' kg-' respectively of Ladrenaline (Antigen Ltd, Roscrea, Ireland), infused at 55 ml/h by a Braun Perfusor VI pump. Blood pressure, heart rate, serum electrolytes and plasma catecholamines were followed for 1.5 h before, during and for 2 h after the infusions.
Blood pressure was measured by a semi-automatic sphygmomanometer (Bosomat) and heart rate by a polygraph (Grass model 7D). The electrocardiogram was continuously displayed on an oscilloscope and also recorded at intervals on the polygraph. Serum electrolyte samples were centrifuged within 30min to prevent haemolysis and subsequently analysed on a Technicon SMA 6/60 (Technical Instrument Corporation, Tarrytown, New York, U.S.A.) by using standard methods. Plasma adrenaline samples were collected into heparinized tubes kept on ice, centrifuged at 4°C and stored at -70°C until assayed. The adrenaline levels were measured by the sensitive radioenzymatic method of Da Prada & Zurcher [13] . The QT interval was measured from the onset of the Q wave to the point where a tangent to the descending limb of the T wave crossed the baseline. The QT interval was corrected for heart rate (QT,) by the Bazett Formula [14] . Statistical analysis was performed by repeated measures of analysis of variance and paired t-tests where appropriate.
Results
The results are given as the mean values? SD. During placebo treatment, the baseline blood pressure was 103 f 9/61 f 7 mmHg and the heart rate was 60 f 6 beatslmin. After atenolol pretreatment the blood pressure was 95 -+ 7/58 f 6 mmHg and the heart rate 51 -+6 beats/min. The dose of atenolol was 50mg twice daily in seven volunteers but in two further volunteers this was required to be increased to 100mg twice daily to produce the same degree of P,-blockade as timolol. After timolol pretreatment, the blood pressure was 98 * 7/55 f 6 mmHg and the heart rate was 52 -+ 7 beatslmin. The dose of timolol was lOmg twice daily in all subjects. Table 1 shows the plasma adrenaline levels before and after 90 min of each infusion. As expected, the plasma levels increased during the infusion of adrenaline. There was, however, no significant difference between the adrenaline levels found during treatment with placebo, atenolol or timolol. Further-TABLE 1. Plasma adrenaline before and after 90 min of each infusion, after pretreatment with placebo, atenolol or timolol The plasma adrenaline levels (means f SD) during each infusion did not differ significantly between the placebo, atenolol or timolol study day (repeated measures analysis of variance). more, the plasma levels found during the adrenaline infusions at 0.06 pg min-' kg-' were similar to those previously found in patients with acute myocardial infarction [6] . The changes in blood pressure and heart rate during infusion of adrenaline at 0.06pgmin-' kg-' were compared with the effects of the control glucose infusion (Fig. 1) . Adrenaline increased systolic blood pressure (+ 11 f 6 mmHg), decreased diastolic pressure (-14 f 9 mmHg) and increased heart rate (+ 7 f 9 beatslmin), although the actual changes produced are small. Atenolol partially prevented all of these haemodynamic effects. After timolol, however, there was a different haemodynamic response to infused adrenaline; the systolic blood pressure rose as before (+12f SmmHg) but the diastolic pressure also rose (+ 19 f 4 mmHg) and there was a compensatory bradycardia (-8 f 5 beats/min). In the presence of non-selective P-blockade infused adrenaline stimulated a-adrenoceptors, causing vasoconstriction and a rise in the diastolic blood pressure with a reflex bradycardia. Similar haemodynamic effects have been reported with another nonselective P-blocker, propranolol [ 151.
The serum potassium changes after the infusion of adrenaline are shown in Fig. 2 . During low dose adrenaline infusion, there was a small fall in the serum potassium and at the higher level (0.06 pg (P<O.OOOl) fall in the serum potassium to 3.22 f 0.25 mmol/l. The serum potassium returned to baseline values 90min after the end of the infusions. Atenolol partially blocks the potassium influx caused by adrenaline whereas after timolol --1k g -1 ) adrenaline caused a highly significant the adrenaline-mediated potassium influx is completely blocked. 
Discussion
Intravenous infusions of adrenaline have haemodynamic, metabolic and electrocardiographic effects. Our study confirms that the levels of plasma adrenaline found after myocardial infarction could cause significant hypokalaemia. The pulse rate and pulse pressure also increase and in the electrocardiogram, there is T wave flattening and prolongation of the QT interval. The latter electrocardiographic changes in particular have been associated with a predisposition to ventricular arrhythmias [16] . In our study, both atenolol and timolol prevented this potentially arrhythmogenic change in ventricular repolarization.
The metabolic effects of adrenaline on potassium homoeostasis were first noted in 1934 by D'Silva, who found that an intravenous bolus of adrenaline in cats caused an immediate shortlived increase followed by a prolonged decrease in the serum potassium [17] . In 1960, Lepeschkin et al. infused adrenaline into normal human subjects and recorded the electrocardiogram changes of a reduction in T wave height and an increase in U wave amplitude [18] . Subsequently, infused adrenaline, at very high dose, was found to cause hypokalaemia in man [ll] . Our study has shown that the levels of plasma adrenaline found after myocardial infarction can cause sigificant hypokalaemia. In coronary care units, approximately 15-20% of all patients have hypokalaemia on admission and this is commoner in those taking thiazide diuretics [8, 10, 191 . Furthermore, these hypokalaemic patients have an increased incidence of ventricular tachycardia and fibrillation [8, 191 . Of the patients with potassium levels less than 3.1 mmol/l, 67% experienced ventricular arrhythmias [8] . This study shows that adrenaline-induced hypokalaemia develops rapidly and also reverses relatively quickly in normal volunteers. We have also previously demonstrated that hypokalaemia during the acute phase of myocardial infarction is often transient [20] . Thus the often quoted figure of 20% having hypokalaemia in coronary care units may be an underestimate, especially if one considers those who die before reaching hospital.
The present study helps to characterize the type of 0-adrenoceptor responsible for adrenalinemediated potassium influx. Our results are similar to those obtained in salbutamol-induced hypokalaemia, where practolol partially blocked but propranolol completely blocked potassium influx
In man, there is circumstantial evidence linking &-adrenoceptors to Na+/K+-ATPase in studies of &blockade during open heart surgery [4, 51. Our study suggests that either Na+/K+-ATPase is linked to both PI-and &receptors or that PZ-adrenoceptors alone are responsible and atenolol at the dose used is only relatively cardioselective, exerting some action on P,-receptors.
Evidence is accumulating that p-blockade is beneficial in the secondary prevention of myocardial infarction [22-271. There are many potentially beneficial properties of pblockade after myocardial infarction in addition to the direct anti-arrhythmic or membrane stabilizing effect [28] . The reduction in oxygen demand with its resulting decreased infarct size would also seem to be of prime importance [29] . Seemingly of lesser importance are the antagonistic effects of &blockade on the transmembrane flux of sodium, potassium or calcium [ l l , 301. Overall the beneficial effects of &blockade after myocardial infarction are likely to be multifactorial. The present study, however, demonstrates the importance of metabolic factors and in particular the inhibition of adrenaline-mediated potassium influx and hypokalaemia.
In our study, there was a difference between cardio-selective and non-selective P-blockade. Atenolol reduced the fall in serum potassium but did not, as timolol did, block it completely. In contrast, timolol but not atenolol caused an increase in diastolic blood pressure due to unopposed aadrenoceptor-mediated vasoconstriction. This increase in diastolic pressure may be undesirable, at least in the acute phase of myocardial infarction. It would seem that cardioselective &blockers have a haemodynamic advantage whereas non-selective &blockers have a metabolic advantage. It remains unclear, however, whether haemodynamic or metabolic factors are of more importance during increased sympathoadrenal activity.
